EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic target

Toner, K; Bollard, CM

Bollard, CM (通讯作者),Childrens Natl Hlth Syst, Ctr Canc & Immunol Res, 111 Michigan Ave NW, Washington, DC 20010 USA.

BLOOD, 2022; 139 (7): 983

Abstract

Epstein-Barr virus (EBV) is a ubiquitous human tumor virus, which contributes to the development of lymphoproliferative disease, most notably in patie......

Full Text Link